• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer.

作者信息

Perachino Marta, Poggio Francesca, Lambertini Matteo

机构信息

Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genova, Italy.

Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.

出版信息

Breast Cancer Res Treat. 2020 Aug;183(1):239-240. doi: 10.1007/s10549-020-05767-3. Epub 2020 Jun 28.

DOI:10.1007/s10549-020-05767-3
PMID:32596767
Abstract
摘要

相似文献

1
Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer.呼吁评估铂类化疗对早期乳腺癌的治疗诱导性腺毒性。
Breast Cancer Res Treat. 2020 Aug;183(1):239-240. doi: 10.1007/s10549-020-05767-3. Epub 2020 Jun 28.
2
Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial.密集型剂量表阿霉素、紫杉醇、环磷酰胺与每周紫杉醇、脂质体多柔比星（三阴性乳腺癌加卡铂）在高危早期乳腺癌新辅助治疗中的对比（GeparOcto-GBG 84）：一项随机 III 期试验。
Eur J Cancer. 2019 Jan;106:181-192. doi: 10.1016/j.ejca.2018.10.015. Epub 2018 Dec 5.
3
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple-negative, early-stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open-label phase II trial.新辅助多西他赛加卡铂与表柔比星加环磷酰胺序贯多西他赛治疗三阴性早期乳腺癌（NeoCART）：一项多中心、随机对照、开放标签的 II 期临床试验结果。
Int J Cancer. 2022 Feb 15;150(4):654-662. doi: 10.1002/ijc.33830. Epub 2021 Oct 7.
4
Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer.卡铂联合紫杉类药物并不劣于表柔比星联合环磷酰胺序贯紫杉类药物作为早期三阴性乳腺癌的辅助化疗。
Breast Cancer Res Treat. 2020 Jul;182(1):67-77. doi: 10.1007/s10549-020-05648-9. Epub 2020 May 11.
5
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.在三阴性乳腺癌（BrighTNess）中，将 PARP 抑制剂 veliparib 联合卡铂或卡铂单药添加到标准新辅助化疗中：一项随机、3 期试验。
Lancet Oncol. 2018 Apr;19(4):497-509. doi: 10.1016/S1470-2045(18)30111-6. Epub 2018 Feb 28.
6
[Activity of paclitaxel, epirubicin and carboplatin in patients with advanced or recurrent endometrial cancer].紫杉醇、表柔比星和卡铂治疗晚期或复发性子宫内膜癌患者的活性
Nihon Rinsho. 2004 Oct;62 Suppl 10:360-4.
7
Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up.在 2 期临床试验中，早期三阴性乳腺癌中辅助表柔比星加环磷酰胺序贯紫杉类药物与卡铂加紫杉类药物的更新疗效：中位随访 8.1 年。
Breast Cancer Res Treat. 2022 Jan;191(1):97-105. doi: 10.1007/s10549-021-06401-6. Epub 2021 Oct 14.
8
Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer.评估每周一次紫杉醇联合卡铂序贯蒽环类化疗药物在三阴性乳腺癌患者新辅助治疗中的应用效果。
Hematol Oncol Stem Cell Ther. 2018 Mar;11(1):30-33. doi: 10.1016/j.hemonc.2017.07.006. Epub 2017 Oct 28.
9
Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer.基于卡铂的腹腔内化疗用于上皮性卵巢癌。
Gynecol Oncol. 2005 Apr;97(1):10-5. doi: 10.1016/j.ygyno.2004.12.005.
10
[Clinical experience in the treatment of ovarian carcinoma and the role of the nurse during the hemotherapy].
Akush Ginekol (Sofiia). 2009;48 Suppl 2:33-6.

引用本文的文献

1
Ovarian toxicity of carboplatin and paclitaxel in mouse carriers of mutation in BRIP1 tumor suppressor gene.BRIP1 肿瘤抑制基因突变小鼠载体中卡铂和紫杉醇的卵巢毒性。
Sci Rep. 2022 Feb 1;12(1):1658. doi: 10.1038/s41598-022-05357-x.
2
Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis.铂类新辅助化疗用于三阴性乳腺癌：一项系统评价与荟萃分析
J Int Med Res. 2020 Oct;48(10):300060520964340. doi: 10.1177/0300060520964340.
3
Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.
年轻乳腺癌患者肿瘤生育咨询中的热点问题
Breast Cancer (Auckl). 2020 Sep 4;14:1178223420954179. doi: 10.1177/1178223420954179. eCollection 2020.